Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCI | P41743 | 1/20 | 0.68 |
| ▸ | ACHE | P22303 | 3/20 | 0.66 |
| ▸ | BACE1 | P56817 | 1/20 | 0.60 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.53 |
| ▸ | ESR1 | P03372 | 3/20 | 0.53 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.47 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.47 |
| ▸ | CASP1 | P29466 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | TNF | P01375 | 1/20 | 0.47 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4856507 | 0.98 | ACHE (0.69) | PRKCIACHEBACE1ESR2ESR1 | |
| SCHEMBL5381058 | 0.83 | PRKCI (0.63) | PRKCIACHEBACE1ESR2ESR1 | |
| SCHEMBL9204022 | 0.82 | PRKCI (0.57) | PRKCIACHEBACE1ESR2PDE10A | |
| SCHEMBL454663 | 0.82 | CASP1 (0.52) | PRKCIACHEBACE1ESR2ESR1 | |
| SCHEMBL11682542 | 0.82 | PRKCI (0.49) | PRKCIACHEBACE1ESR2ESR1 | |
| SCHEMBL30597925 | 0.81 | PRKCI (0.61) | PRKCIACHEBACE1ESR2PDE10A | |
| SCHEMBL29358019 | 0.81 | PRKCI (0.61) | PRKCIACHEBACE1ESR2PDE10A | |
| SCHEMBL111004 | 0.81 | PRKCI (0.61) | PRKCIACHEBACE1ESR2PDE10A | |
| SCHEMBL111109 | 0.81 | PRKCI (1.00) | PRKCIACHEBACE1PDE10AHSP90AA1 | |
| SCHEMBL29565648 | 0.81 | PRKCI (1.00) | PRKCIACHEBACE1PDE10AHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117164745-A | Composite material for microporous membrane, composite ion exchange membrane and application of composite material | 国家电投集团氢能科技发展有限公司 | 2023-12-05 | — | — | CN | claimed |
| CN-117126311-A | Polymer, composite, ion exchange membrane and preparation method and application thereof | 国家电投集团氢能科技发展有限公司 | 2023-11-28 | — | — | CN | claimed |
| CN-116808842-B | Modified microporous membrane, composite ion exchange membrane, and preparation methods and applications thereof | 国家电投集团氢能科技发展有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-116808842-A | Modified microporous membrane, composite ion exchange membrane, and preparation methods and applications thereof | 国家电投集团氢能科技发展有限公司 | 2023-09-29 | — | — | CN | claimed |
| CN-109053800-A | Quaternary alkylphosphonium salt support chiral amino-thiocarbamide and its preparation method and application | 湖北大学 | 2018-12-21 | — | — | CN | claimed |
| EP-2004164-B1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING INFLAMMATORY DISEASES | NEUROTECH PHARMACEUTICALS CO LTD (KR) | 2018-08-08 | — | — | EP | claimed |
| US-9102589-B2 | Reactive distillation process for preparation of acetaminophen | GRANULES INDIA LIMITED (IN) | 2015-08-11 | — | — | US | claimed |
| CN-103483214-A | Compound, preparation method thereof and applications of compound in prevention of ulcerative colitis | UNIV XI AN JIAOTONG | 2014-01-01 | — | — | CN | claimed |
| US-20120065423-A1 | REACTIVE DISTILLATION PROCESS FOR PREPARATION OF ACETAMINOPHEN | GRANULES INDIA LIMITED (IN) | 2012-03-15 | — | — | US | claimed |
| CN-1264498-C | Primary intermediates for oxidative dyeing of hair | PROCTER & GAMBLE (US) | 2006-07-19 | — | — | CN | claimed |
| WO-2001097754-A2 | AGENT FOR DYEING FIBRES CONTAINING KERATIN, CONTAINING AT LEAST ONE QUINOXALINE DERIVATIVE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-12-27 | — | — | WO | claimed |
| WO-2001089587-A2 | AGENTS FOR DYEING FIBRES CONTAINING KERATIN | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-11-29 | — | — | WO | claimed |
| WO-2001089460-A2 | COLORANT FOR FIBRES CONTAINING KERATIN | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-11-29 | — | — | WO | claimed |
| EP-1139988-A1 | AGENT FOR DYING KERATIN FIBERS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2001-10-10 | — | — | EP | claimed |
| WO-2001047485-A1 | AGENT FOR COLOURING FIBRES CONTAINING KERATIN | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-07-05 | — | — | WO | claimed |
| WO-2001030312-A1 | MEANS FOR COLOURING KERATIN CONTAINING FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-05-03 | — | — | WO | claimed |
| WO-2001010398-A1 | AGENT FOR DYING KERATIN FIBERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-02-15 | — | — | WO | claimed |
| WO-2000038633-A1 | AGENT FOR DYING KERATIN FIBERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-07-06 | — | — | WO | claimed |
| WO-2000038634-A1 | AGENT FOR DYING KERATIN FIBERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-07-06 | — | — | WO | claimed |
| EP-0269914-A1 | Composition and process for the oxidative dyeing of hair on the basis of 3-(2',2',2'-trifluorethyl)aminophenol derivatives, and 3-(2',2',2'-trifluorethyl)aminophenol derivatives | Wella Aktiengesellschaft (DE) | 1988-06-08 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120065423-A1 | REACTIVE DISTILLATION PROCESS FOR PREPARATION OF ACETAMINOPHEN | CYP2E1, NAT1, ADH1A | PRKCI 4323/4885ACHE 625/4885BACE1 4217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.